Super chemotherapy will be Big Pharma’s next tussle, writes aimeedonnellan
AstraZeneca said on May 5 that the U.S. Food and Drug Administration approved Enhertu to treat metastatic and early stage breast cancer.
In the study, Enhertu cut the risk of disease progression by 72% versus Roche’s Kadcyla. After one year 94.1% of patients on Enhertu were still alive versus 85.9% on Kadcyla. On March 16, French pharmaceutical group Sanofi said it is teaming up with U.S.-listed Seagen to create antibody drug conjugates that would target three different cancers.A patient is seen having a minor surgery to receive chemotherapy the Misurata Cancer Center in Misurata, Libya August 5, 2018.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Dragon Ball Super Promo Teases the Outcome of Bardock's Big WishDragon Ball Super is teasing the outcome of Bardock's big wish for his sons with the promo for the [...]
Les mer »
Public school arts funding needs a big boost from the mayor, advocates and lawmakers sayLawmakers, artists and educators are calling on Mayor Adams to boost funding for arts in schools, arguing the pandemic has made it even more vital for students to be able to express themselves through dance, music and visual art.
Les mer »
Eurovision 2022: Ukraine band releases new war video after big win'Stefania' was written as a tribute to the lead singer's mother, but since Russia’s invasion it has become an anthem to the motherland.
Les mer »
The Weeknd & Charlotte Cardin Win Big at 2022 Juno Awards’ ‘Opening Night Awards’ (Full Winners List)Hill Kourkoutis became the first woman to win recording engineer of the year. WondaGurl became the first woman to win producer of the year twice.
Les mer »
DeuxMoi’s Big HBO Deal Is Changing the Celeb-Gossip GameThe anonymous gossip queen entertained us all throughout the pandemic. But how will she dish on her “Euphoria” favorites (among others) now that she’s on HBO’s payroll?
Les mer »
Opinion | The Super Immunity of Our Fabulously Wealthy Corporate Dictators'The contrast between the old and new corporate dictators,' writes RalphNader, 'is that the latter use, for free, your personal data for a fantastically profitable sale.'
Les mer »